{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:53:10Z","timestamp":1776185590431,"version":"3.50.1"},"reference-count":11,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Imipenem is approved by the U.S. Food and Drug Administration (FDA) for treatment of infections caused by\n            <jats:italic>Enterococcus faecalis<\/jats:italic>\n            . However, there are no NCCLS guidelines for testing susceptibility of enterococci against imipenem. To assess whether or not ampicillin or penicillin could be used as a surrogate for broth microdilution (BMD) testing of imipenem versus\n            <jats:italic>Enterococcus<\/jats:italic>\n            species, 633 strains of\n            <jats:italic>E. faecalis<\/jats:italic>\n            ,\n            <jats:italic>E. faecium<\/jats:italic>\n            , and other enterococci isolated from blood cultures of patients at three geographically distinct university hospitals were tested by the NCCLS BMD and disk diffusion (DD) methods. Using FDA susceptibility breakpoints for imipenem and NCCLS breakpoints for penicillin and ampicillin, categorical agreement (CA) for penicillin-imipenem and ampicillin-imipenem tested with\n            <jats:italic>E. faecalis<\/jats:italic>\n            and\n            <jats:italic>E. faecium<\/jats:italic>\n            by BMD was \u226594% but was \u226490% for other enterococci. Using the DD method, CA for ampicillin-imipenem tested with\n            <jats:italic>E. faecalis<\/jats:italic>\n            and\n            <jats:italic>E. faecium<\/jats:italic>\n            was \u226598% and was 92% for other enterococci; CA for penicillin-imipenem was 91% for\n            <jats:italic>E. faecalis<\/jats:italic>\n            , 98% for\n            <jats:italic>E. faecium<\/jats:italic>\n            , and 87% for other enterococci. Further analysis showed that testing\n            <jats:italic>E. faecalis<\/jats:italic>\n            with ampicillin resulted in no false-susceptible (FS) or false-resistant (FR) results by BMD, no FS results by DD, and a single FR result by DD (0.2%), whereas testing with penicillin resulted in no FS results by BMD or DD and two FR results by BMD (0.4%). For\n            <jats:italic>E. faecium<\/jats:italic>\n            and other enterococci, the combination of FS and FR results was such that surrogate testing with penicillin or ampicillin appears not to be sufficiently reliable to be used clinically. We conclude that ampicillin is an accurate predictor of the in vitro activity of imipenem against\n            <jats:italic>E. faecalis<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1128\/jcm.42.8.3747-3751.2004","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T18:08:04Z","timestamp":1091729284000},"page":"3747-3751","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Multicenter Evaluation of Use of Penicillin and Ampicillin as Surrogates for In Vitro Testing of Susceptibility of Enterococci to Imipenem"],"prefix":"10.1128","volume":"42","author":[{"given":"Melvin P.","family":"Weinstein","sequence":"first","affiliation":[{"name":"Departments of Medicine"},{"name":"Pathology, Robert Wood Johnson Medical School"},{"name":"Microbiology Laboratory, Robert Wood Johnson University Hospital, New Brunswick, New Jersey 08901-0019"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Mirrett","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Kannangara","sequence":"additional","affiliation":[{"name":"Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Monahan","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Duke University Medical Center, Durham, North Carolina 27710"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizzie J.","family":"Harrell","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan C.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Barth","family":"Reller","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine"},{"name":"Microbiology Laboratory, University of Colorado Hospital, Denver, Colorado 80220"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"183","volume":"9","year":"1982","unstructured":"Cohn, D. L., L. G. Reimer, and L. B. Reller. 1982. Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J. Antimicrob. Chemother.9:183-194.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.5.789"},{"key":"e_1_3_1_4_2","first-page":"297","year":"1999","unstructured":"Facklam, R. R., D. F. Sahm, and L. M. Teixeira. 1999. Enterococcus, p. 297-305. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.","journal-title":"Manual of clinical microbiology, 7th ed."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.18.4.557"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.Supplement_3.S411"},{"key":"e_1_3_1_7_2","unstructured":"NCCLS. 2000. Performance standards for antimicrobial disk susceptibility tests. Approved standard 7th ed. NCCLS document M2-A7. NCCLS Wayne Pa."},{"key":"e_1_3_1_8_2","unstructured":"NCCLS. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 5th ed. NCCLS document M7-A5. NCCLS Wayne Pa."},{"key":"e_1_3_1_9_2","unstructured":"NCCLS. 1998. Development of in vitro susceptibility testing criteria and quality control parameters. Tentative guideline 3rd ed. NCCLS document M23-T3. NCCLS Wayne Pa."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.1.180"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.23.3.421-424.1986"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.7.2729-2731.2001"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.8.3747-3751.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.42.8.3747-3751.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T03:13:48Z","timestamp":1646450028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.42.8.3747-3751.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1128\/JCM.42.8.3747-3751.2004"],"URL":"https:\/\/doi.org\/10.1128\/jcm.42.8.3747-3751.2004","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"2004-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-04-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}